Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Breast Cancer Treatment Studies, Lung Cancer Treatments and Mutations, Advanced Breast Cancer Therapies, and Colorectal Cancer Treatments and Studies.
Complications From Transcatheter Pulmonary Valve Replacement With Self-Expanding Prestent
Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival
National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)
The New NCI Precision Medicine Trials
Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer
Assessment of Racial Disparity in Survival Outcomes for Early Hormone Receptor–Positive Breast Cancer After Adjusting for Insurance Status and Neighborhood Deprivation
Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial
Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2–Activating Mutations: Results From the National Cancer Institute–Molecular Analysis for Therapy Choice ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-B
Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: stronger evidence, greater trust
Association of Modifiable Risk Factors With Early Discontinuation of Adjuvant Endocrine Therapy
Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF<sup>V600E</sup></i> Mutations: Results of the NCI-MATCH Trial Subprotocol H
Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial
Effect of Capivasertib in Patients With an <i>AKT1 E17K</i>-Mutated Tumor
Dual anti-CTLA-4 and anti-PD-1 blockade in metaplastic carcinoma of the breast: Dart (SWOG S1609, Cohort 36).
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
Nivolumab Is Effective in Mismatch Repair–Deficient Noncolorectal Cancers: Results From Arm Z1D—A Subprotocol of the NCI-MATCH (EAY131) Study
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy
Abstract CT138: NCI-MATCH EAY131 -Z1I: Phase II study of AZD1775, a wee-1 kinase inhibitor, in patients with tumors containing <i>BRCA1</i> and <i>BRCA2</i> mutations
Abstract CT138: NCI-MATCH EAY131 -Z1I: Phase II study of AZD1775, a wee-1 kinase inhibitor, in patients with tumors containing<i>BRCA1</i>and<i>BRCA2</i>mutations
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies
Molecular analysis for therapy choice (MATCH) arm W: Phase II study of AZD4547 in patients with tumors with aberrations in the FGFR pathway.
Abstract GS1-01: Increasing the dose density of adjuvant chemotherapy by shortening intervals between courses or by sequential drug administration significantly reduces both disease recurrence and breast cancer mortality: An EBCTCG meta-analysis of 21,000 women in 16 randomised trials
Ado-trastuzumab emtansine (T-DM1) in patients (pts) with HER2 amplified (amp) tumors excluding breast and gastric/gastro-esophageal junction (GEJ) adenocarcinomas: Results from the National Cancer Institute (NCI) Molecular Analysis for Therapy Choice (MATCH) trial.
A metastasis biomarker (MetaSite <i>Breast</i>™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancer.
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
Recurrence score and clinicopathologic characteristics of TAILORx participants by race and ethnicity.
Source Coding and Simulation
RI: Statistical Modeling of Prosodic Features in Speech Technology
Travel Support for a Workshop on Mentoring for Academia
Quantization for Signal Compression, Classification, and Mixture Modeling
Gauss Mixture Quantization for Image Compression and Segmentation
Compression, Classification and Image Segmentation
U.S.-France Cooperative Research: Combined Compression and Classification
ES Postdoctoral Associate: Image Compression and the Evaluation of Quality
Tree-structured Image Compression and Classification
Circular Dichroism Spectrometer
Image Compression Using Vector Quantization and Decision Trees
Analog to Digital Conversion and Data Compression
Analog to Digital Conversion and Data Compression
The Application of Information Theory to Pattern Recognitionand the Design of Decision Tree Classifiers (Information Science)
Information Theory and Data Compression
Information Theory and Data Compression
Rate Distortion Approach to Data Compression
Instructional Scientific Equipment Program
Kinetics of the Quaternary Structural Transition of Hemoglobin